EXAS
EXACT SCIENCES CORP
Nasdaq Services-Medical Laboratories Large accelerated filer

Key Financials

Net Income
$-207949000
↑ 79.8%
Operating Income
$-206298000
↑ 80.3%
Revenue
$3.2B
↑ 17.7%
Gross Profit
$2.3B
↑ 17.9%
EPS (Diluted)
$-1.10
↑ 80.3%
Total Assets
$5.9B
↓ 1.1%
Total Liabilities
$3.5B
↓ 1.9%
Shareholders' Equity
$2.4B
↓ 0.0%

Recent SEC Filings

Form Type Filed Date Link
15-12G 4/2/2026 View on SEC
SCHEDULE 13G/A 3/26/2026 View on SEC
POSASR 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC
S-8 POS 3/23/2026 View on SEC

Company Information

Field Value
Ticker EXAS
Company Name EXACT SCIENCES CORP
CIK 1124140
Sector Services-Medical Laboratories
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 1231
Phone 608-284-5700